Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 7/20 | 0.65 |
| ▸ | RIN1 | Q13671 | 7/20 | 0.65 |
| ▸ | NR2E3 | Q9Y5X4 | 3/20 | 0.65 |
| ▸ | PPARG | P37231 | 2/20 | 0.65 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.65 |
| ▸ | IDE | P14735 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | NSD2 | O96028 | 3/20 | 0.49 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | HLCS | P50747 | 2/20 | 0.45 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.44 |
| ▸ | GBA1 | P04062 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6561453 | 1.00 | ABL1 (0.65) | ABL1RIN1NR2E3PPARGNCOR2 | |
| SCHEMBL30980800 | 0.83 | ABL1 (0.68) | ABL1RIN1NR2E3PPARGNCOR2 | |
| SCHEMBL20635796 | 0.82 | TDP1 (0.66) | ABL1RIN1NR2E3PPARGNCOR2 | |
| SCHEMBL21957563 | 0.82 | TDP1 (0.66) | ABL1RIN1NR2E3PPARGNCOR2 | |
| SCHEMBL2381946 | 0.79 | ALDH1A1 (0.47) | ABL1RIN1NR2E3PPARGNCOR2 | |
| SCHEMBL143996 | 0.79 | ABL1 (1.00) | ABL1RIN1NR2E3PPARGNCOR2 | |
| SCHEMBL19008240 | 0.79 | ABL1 (0.77) | ABL1RIN1NR2E3PPARGNCOR2 | |
| SCHEMBL22652870 | 0.79 | ABL1 (0.77) | ABL1RIN1NR2E3PPARGNCOR2 | |
| SCHEMBL143997 | 0.79 | ABL1 (1.00) | ABL1RIN1NR2E3PPARGNCOR2 | |
| SCHEMBL14956497 | 0.79 | ABL1 (1.00) | ABL1RIN1NR2E3PPARGNCOR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240262844-A1 | PYRIDINIUM SALTS AND METHODS OF USE | UNIV WYOMING (US) | 2024-08-08 | — | — | US | disclosed |
| US-20240262845-A1 | PYRIDINIUM SALTS, METHODS OF MAKING, AND METHODS OF USE | UNIV WYOMING (US) | 2024-08-08 | — | — | US | disclosed |
| WO-2024155932-A1 | PYRIDINIUM SALTS AND METHODS OF USE | UNIVERSITY OF WYOMING (US) | 2024-07-25 | — | — | WO | disclosed |
| WO-2024155935-A2 | PYRIDINIUM SALTS, METHODS OF MAKING, AND METHODS OF USE | UNIVERSITY OF WYOMING (US) | 2024-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240262845-A1 | PYRIDINIUM SALTS, METHODS OF MAKING, AND METHODS OF USE | KYNU, TPH1, AADAT | ABL1 124/4885RIN1 3871/4885NR2E3 3081/4885 |
| US-20240262844-A1 | PYRIDINIUM SALTS AND METHODS OF USE | KYNU, TPH1, AADAT | ABL1 99/4885RIN1 3766/4885NR2E3 2862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.